Oral Testosterone Therapy Jatenzo Faces CV, Sampling Tube Issues At Advisory Cmte

US FDA questions Clarus product's long-term safety in briefing documents for Bone, Reproductive and Urologic Drugs Advisory Committee meeting.

tubes
Are these the correct tubes to use?

In addition to discussing potential cardiovascular worries associated with Clarus Therapeutics Inc.'s proposed oral testosterone replacement therapy Jatenzo, a US FDA advisory committee also will consider whether the type of tube used to collect samples for dose titration will affect the safe use of the product.

Jatenzo (testosterone undecanoate) is vying for approval as an oral testosterone therapy. The Bone, Reproductive and Urologic Drugs Advisory Committee...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from US FDA Performance Tracker

More from Regulatory Trackers